Byline: Olivia Dimmer
-
Improving Cancer Detection for Women with Dense Breasts
The use of ultrasound screening and 3D mammography only slightly increases the detection rate of breast cancer in women with dense breasts, according to a prospective multicenter study published in the Journal of Clinical Oncology.
-
Reducing Seizures After Brain Tumor Treatment
Northwestern Medicine investigators have shown that inhibiting a mutated gene can reduce seizure activity in adult-type diffuse gliomas, according to a study published in the Journal of Clinical Investigation.
-
Celebrating Advances in Alzheimer’s Research and Clinical Care
Attendees gathered on May 11 for Alzheimer Day, an annual event hosted by the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease to showcase dementia and aging research conducted throughout Northwestern and bring those discoveries to the community.
-
Understanding How Hormones Influence Anemia
Northwestern Medicine scientists have uncovered how peptides produced by bones during inflammation prevent anemia in mice, according to a recent study published in the journal Blood.
-
Groundbreaking Geneticist Delivers Epigenetics Lecture
Huda Yahya Zoghbi, MD, the inaugural winner of the 2016 Mechthild Esser Nemmers Prize in Medical Science at Northwestern University, returned to Feinberg on Monday as part of the Simpson Querrey Institute for Epigenetics Distinguished Lecturer Series.
-
Investigating the Benefits of Salt Substitutes in Elderly Patients
Salt substitutes may be effective in lowering blood pressure and reducing cardiovascular events in residents of elderly care facilities, according to a recent multi-center study published in Nature Medicine.
-
Understanding How Aggressive Thyroid Cancer Evolves
Northwestern Medicine scientists have shed new light on how the deadliest form of thyroid cancer becomes more aggressive, according to research published in the Journal of Clinical Investigation.
-
Honoring the MD Class of 2023
Feinberg honored the MD Class of 2023 during the medical school’s 164th commencement ceremony in the Aon Grand Ballroom at Navy Pier.
-
Improving Immune Responses in Prostate Cancer
Men with high-risk prostate cancer who received immunotherapy treatment with enoblituzumab in the weeks leading up to surgery had favorable rates of disease remission and tumor downgrading after surgery, according to a recent study published in Nature Medicine.
-
Combination Treatment Improves Survival in Endometrial Cancer
Patients with endometrial cancer who received the immunotherapy drug pembrolizumab in addition to chemotherapy had longer progression-free survival compared to chemotherapy alone, according to a recent clinical trial published in the New England Journal of Medicine.
